Stay updated on INCAGN01876 Combo Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INCAGN01876 Combo Immune Therapies Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:53:24.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the safety, tolerability, and efficacy evaluation of INCAGN01876 in combination with immune therapies for subjects with advanced or metastatic malignancies in a Phase 1/2 study.
    Difference
    0.1%
    Check dated 2024-06-06T14:43:58.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying conditions such as locally advanced or metastatic disease and other health-related requirements. Previously, this section only indicated that no information was provided.
    Difference
    16%
    Check dated 2024-05-22T21:25:48.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:45:26.000Z thumbnail image

Stay in the know with updates to INCAGN01876 Combo Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.